Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672053 | SCV000797112 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2018-01-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868261 | SCV002147558 | pathogenic | Walker-Warburg congenital muscular dystrophy | 2021-12-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FKRP protein in which other variant(s) (p.Ala455Asp) have been determined to be pathogenic (PMID: 14652796, 15574464, 16368217, 18671187, 19955119, 23420653, 23894383). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 556102). This variant has not been reported in the literature in individuals affected with FKRP-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg176*) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 320 amino acid(s) of the FKRP protein. |
Baylor Genetics | RCV003459634 | SCV004197417 | likely pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2023-07-22 | criteria provided, single submitter | clinical testing |